文献速递免疫规划传染病防控与疫情报告

10价肺炎球菌结合疫苗(PCV10)对健康儿童及急性中耳炎和肺炎患儿肺炎球菌携带的影响:克罗地亚血清型3、6C和19A的出现

Impact of the 10-valent pneumococcal conjugate vaccine (PCV10) on pneumococcal carriage in healthy children and children with acute otitis media and pneumonia: emergence of serotypes 3, 6C and 19A in Croatia.
PubMed 文献 · Vaccine · 2025-02-07

2019年克罗地亚引入PCV10后开展横断面研究,比较引入前后健康儿童及肺炎/急性中耳炎患儿肺炎球菌血清型分布。健康儿童携带率从19.9%升至28.7%,非疫苗血清型增加,6C、11A、19A、23A风险显著升高;患者中血清型3增加并成为主要分离株,3型和19A几乎导致全部复杂性肺炎。

要点

  • 健康儿童肺炎球菌携带率从19.9%升至28.7%,主要由非疫苗血清型增加所致。
  • 暴露儿童中6C、11A、19A、23A血清型调整后风险显著高于对照儿童。
  • 肺炎/急性中耳炎患儿中血清型3增加,与复杂性肺炎风险升高相关。

核心结论

  • 接种后早期观察到PCV10相关血清型6C和19A显著增加。
  • 黏膜感染患者中血清型3令人担忧地上升且复杂性肺炎风险更高,持续监测至关重要。

研究设计与样本

  • 在PCV10引入前后开展横断面研究,采集1500名48月龄以下健康儿童鼻咽拭子。
  • 另纳入324名18岁以下肺炎和/或急性中耳炎且分离出肺炎链球菌的儿童。
  • 采用常规方法鉴定菌株,Quellung反应进行血清分型,纸片扩散法和梯度试验检测抗菌药物敏感性。
  • 报告暴露与对照儿童间的患病率、绝对风险(患病率)差(RD)和相对风险(患病率)比(RR)。

主要发现

  • 健康儿童携带率从19.9%升至28.7%,主要因非疫苗血清型增加。
  • 健康暴露儿童中6C(RR 3.18;95%CI 1.43-7.06)、11A(RR 2.8;95%CI 1.22-6.39)、19A(RR 4.18;95%CI 1.18-14.9)、23A(RR 3.93;95%CI 1.87-8.24)的调整后概率显著更高。
  • 肺炎/急性中耳炎暴露儿童中这些血清型患病率也更高。
  • 该队列中血清型3增加(RR 4.6;95%CI 2.02-10.3),成为PCV10后总体研究人群的主要分离株。
  • 血清型3和19A几乎完全导致复杂性肺炎,其概率增加21倍。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: In 2019, the 10-valent pneumococcal conjugate vaccine (PCV10) was introduced in the Croatian immunization programme, a first for this European PCV-naïve country. This study aimed to evaluate the impact of PCV10 on pneumococcal serotype distribution among asymptomatic children and children with pneumonia and/or acute otitis media. METHODS: Cross-sectional studies were conducted before and after the PCV10 introduction, with nasopharyngeal swabs collected from 1500 healthy children under 48 months of age. An additional 324 children under 18 years with pneumonia and/or acute otitis media, from whom Streptococcus pneumoniae was isolated, were also included. Isolates were identified by conventional methods, serotyped by Quellung reaction, and tested for antimicrobial susceptibility using disk diffusion and gradient test methods. We report prevalence, absolute risk (prevalence) difference (RD) and relative risk (prevalence) ratio (RR) differences between exposed and control children. RESULTS: Carriage prevalence among healthy children increased from 19.9% to 28.7%, primarily due to a rise in non-vaccine serotypes (NVT). Adjusted probabilities for serotypes 6C (RR 3.18; 95% CI, 1.43-7.06), 11A (RR 2.8; 95% CI, 1.22-6.39), 19A (RR 4.18; 95% CI, 1.18-14.9) and 23A (RR 3.93; 95% CI, 1.87-8.24) were significantly higher in healthy exposed children. Prevalences of these serotypes were also higher in exposed children with pneumonia/acute otitis media. In this cohort, serotype 3 increased (RR 4.6; 95% CI, 2.02-10.3), becoming the leading post-PCV10 isolate in the overall studied population. Serotypes 3 and 19A were almost entirely responsible for complicated pneumonia cases for which the probability increased by 21-fold. Antimicrobial susceptibility remained similar across periods. CONCLUSIONS: In the early post-vaccine period significant increase of PCV10 vaccine-related serotypes (6C, 19A) was observed. Continued monitoring is also essential due to concerning rise of serotype 3 in patients with mucosal infections and a higher risk for complicated pneumonia.

来源:Vaccine,查看原文。版权归原作者所有。

引用

  1. Krajcar N, Trkulja V, Butić I, et al. Impact of the 10-valent pneumococcal conjugate vaccine (PCV10) on pneumococcal carriage in healthy children and children with acute otitis media and pneumonia: emergence of serotypes 3, 6C and 19A in Croatia. Vaccine. 2025. PMID: 39921981. doi:10.1016/j.vaccine.2025.126848

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。